Company Description
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States.
Its product, DeepView System, uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye, at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely and informed decision regarding the treatment of the patient’s wounds.
The company’s system also includes MSI imaging technology, a proprietary multi-spectral optics and sensors, capturing injured tissue images; and AI-Burn software.
Spectral AI, Inc. is headquartered in Dallas, Texas.
| Country | United States |
| Founded | 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 78 |
| CEO | Peter Carlson |
Contact Details
Address: 2515 McKinney Avenue, Suite 1000 Dallas, Texas 75201 United States | |
| Phone | 972 499 4934 |
| Website | spectral-ai.com |
Stock Details
| Ticker Symbol | MDAI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001833498 |
| CUSIP Number | 84757T105 |
| ISIN Number | US84757T1051 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Erich L. Spangenberg | Chief Executive Officer of Health care and Director |
| Wensheng Fan | Co-Founder, Chief Innovation Strategist and Senior Advisor to the Chief Executive Officer |
| Vincent Stanley Capone | Chief Financial Officer, General Counsel and Corporate Secretary |
| Christine Marks | Vice President of Marketing and Commercialization |
| Dr. John Michael DiMaio M.D. | Founder and Chairman |
| Stan Micek | Interim Chief Operating Officer |
| Prof. Paul Chadwick | Executive Vice President of UK and EMEA |
| Jeremiah A. Sparks MBA | Chief Commercialization Officer |
| David Bronson | Financial Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 17, 2025 | DEF 14A | Other definitive proxy statements |
| Apr 2, 2025 | 8-K | Current Report |
| Mar 31, 2025 | 10-K | Annual Report |
| Mar 26, 2025 | 8-K | Current Report |
| Mar 21, 2025 | 424B5 | Filing |
| Mar 17, 2025 | 8-K | Current Report |
| Mar 4, 2025 | 8-K | Current Report |
| Mar 4, 2025 | 8-K | Current Report |
| Mar 4, 2025 | 8-K | Current Report |